JTV-519 hemifumarate
CAS: 145903-06-6
Ref. 3D-VFA90306
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
- 1,4-Benzothiazepine, 2,3,4,5-tetrahydro-7-methoxy-4-[1-oxo-3-[4-(phenylmethyl)-1-piperidinyl]propyl]-
- 1-(2,3-Dihydro-7-methoxy-1,4-benzothiazepin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-1-propanone
- 1-Propanone, 1-(2,3-dihydro-7-methoxy-1,4-benzothiazepin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-
- 4-[3-[1-(4-Benzyl)piperidinyl]propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine
- Jtv-519
- K-201
- 4-[3-(4-Benzylpiperidin-1-yl)propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine
JTV-519 is a novel compound that has the ability to increase energy metabolism in cells. It was created by altering the chemical structure of an existing drug, which is a cytosolic calcium channel blocker. JTV-519 has been shown to have a positive effect on cardiac function, as well as prevention of congestive heart failure. This drug also reduces diastolic pressure and improves renal function by increasing glomerular filtration rate. JTV-519 also interacts with toll-like receptor 2 and 4 (TLR2/4), which are molecules involved in inflammation and immune response. Experimental data suggests that JTV-519 may be useful for treating cardiovascular diseases such as atrial or ventricular arrhythmias, congestive heart failure, or cardiac hypertrophy.
Chemical properties
Technical inquiry about: 3D-VFA90306 JTV-519 hemifumarate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
